Position in IDXX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$836,092
New position
Shares Held
1,488
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026EntryPoint Capital, LLC holds $2,939,289 across 6 Diagnostics & Research names. IDXX ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
This page
|
1,488 | $836,092 | |
| 2 | SHC |
Sotera Health Co
|
47,819 | $685,724 | |
| 3 | A |
Agilent Technologies, Inc.
|
4,319 | $492,279 | |
| 4 | OPK |
Opko Health, Inc.
|
342,171 | $390,074 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
20,517 | $284,775 | |
| 6 | FLGT |
Fulgent Genetics, Inc.
|
15,745 | $250,345 |
All Filings in IDXX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $836,092 | 1,488 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||